Painless Swab Detects Oral Cancers in an Hour, With Over 95% Accuracy
A new painless brush test can detect oral cancers in one hour with over 95% accuracy, potentially replacing invasive biopsies.
The brief
A new medical diagnostic tool utilizing a brush swab can identify oral cancers within one hour. This method provides a painless alternative to traditional biopsy procedures that require a scalpel.
Coverage from ScienceAlert, Medical Xpress, and NDTV emphasizes the test's speed and high accuracy rate. EurekAlert! and Conexiant have also reported on the technology, with the former providing diagrammatic details of the brush test.
Further developments may focus on the transition from traditional biopsy methods to this brush-based detection system.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
How long does the oral cancer brush test take?
The test can detect oral cancer in one hour.
What is the reported accuracy of the swab?
According to ScienceAlert, the test has over 95% accuracy.
How does this differ from standard biopsy methods?
The brush test is described as painless, whereas traditional biopsies involve the use of a scalpel.
Coverage (5)
- Oral Cancer brush test diagram (IMAGE) EurekAlert! · 12h ago
- Medical Oddities: When a Brush Beats a Scalpel Conexiant · 12h ago
- New One Hour Brush Test Could Detect Oral Cancer Without Painful Biopsy NDTV · 12h ago
- New brush test detects oral cancer in one hour Medical Xpress · 12h ago
- Painless Swab Detects Oral Cancers in an Hour, With Over 95% Accuracy ScienceAlert · 12h ago broke it first
People, places & organizations
Topics
Related trends
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test, Stockholm3, is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.